Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Between Bedside and Bench
  • Published:

Autoimmunity's collateral damage: Immunodeficiency hints at autoreactivity to cytokines

Autoimmunity develops when one's own immune cells and pathogenic antibodies react against the body, causing inflammation, degeneration, tissue destruction and even organ failure. But autoimmunity mediators can also evoke other pathological side effects, and individual factors can worsen the morbidity of the people suffering from autoimmune disorders, adding another level of complexity to these diseases. In 'Bedside to Bench', Mark Anderson and Michael Waterfield peruse a potential link between immunodeficiency and autoimmunity. Autoantibodies against cytokines involved in tackling Candida albicans infection may underlie the trait of increased susceptibility to yeast observed in people with such autoantibodies. In 'Bench to Bedside', Daniel Cua and Jonathan Sherlock discuss how the immune response induced by gut microbiota may be responsible for autoimmune attacks at distant sites, such as the joints.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: APS1 leads to autoantibodies against IL-17 and type I interferons.

Katie Vicari

References

  1. Goyal, R., Bulua, A.C., Nikolov, N.P., Schwartzberg, P.L. & Siegel, R.M. Curr. Opin. Rheumatol. 21, 78–84 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hönig, M. & Schwarz, K. Curr. Opin. Rheumatol. 18, 383–388 (2006).

    Article  PubMed  Google Scholar 

  3. Khiong, K. et al. J. Clin. Invest. 117, 1270–1281 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Perheentupa, J. J. Clin. Endocrinol. Metab. 91, 2843–2850 (2006).

    Article  CAS  PubMed  Google Scholar 

  5. Nagamine, K. et al. Nat. Genet. 17, 393–398 (1997).

    Article  CAS  PubMed  Google Scholar 

  6. Finnish-German APECED Consortium. Nat. Genet. 17, 399–403 (1997).

  7. Anderson, M.S. et al. Science 298, 1395–1401 (2002).

    Article  CAS  PubMed  Google Scholar 

  8. Mathis, D. & Benoist, C. Annu. Rev. Immunol. 27, 287–312 (2009).

    Article  CAS  PubMed  Google Scholar 

  9. Matsumoto, M. Eur. J. Immunol. 41, 12–17 (2011).

    Article  CAS  PubMed  Google Scholar 

  10. Gardner, J.M. et al. Science 321, 843–847 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Kisand, K. et al. J. Exp. Med. 207, 299–308 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Puel, A. et al. J. Exp. Med. 207, 291–297 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Meager, A. et al. PLoS Med. 3, e289 (2006).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Conti, H.R. et al. J. Exp. Med. 206, 299–311 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Puel, A. et al. Science 332, 65–68 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark S Anderson.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waterfield, M., Anderson, M. Autoimmunity's collateral damage: Immunodeficiency hints at autoreactivity to cytokines. Nat Med 17, 1054–1055 (2011). https://doi.org/10.1038/nm0911-1054

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0911-1054

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing